$1.49
-0.03-1.97%
At close: -
$1.52
0.032.01%
After Hours: 4:10 PM EDT
Comments
Loading...
ADC Therapeutics Earnings Estimates, EPS & Revenue | NYSE:ADCT | Benzinga
ADC Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 5
EPS Estimate
$-0.430
Quarterly Revenue Estimate
$20.94M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$70.72M
Analyze the earnings history of ADC Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADCT | ADC Therapeutics | -$0.38 | -$0.43 | — | — | $18.05M | $20.94M | — | — | 05/05/2025 | Get Alert |
| ADCT | ADC Therapeutics | -$0.97 | -$0.35 | -$0.25 | 28.57% | $16.79M | $19.67M | $16.91M | -14.03% | 03/27/2025 | Get Alert |
| ADCT | ADC Therapeutics | -$0.41 | -$0.39 | -$0.28 | 28.21% | $14.49M | $18.46M | $18.46M | 0.02% | 11/07/2024 | Get Alert |
| ADCT | ADC Therapeutics | -$0.39 | -$0.44 | -$0.25 | 43.18% | $19.28M | $18.93M | $17.41M | -8.03% | 08/06/2024 | Get Alert |
| ADCT | ADC Therapeutics | -$0.53 | -$0.56 | -$0.38 | 32.14% | $18.99M | $18.21M | $18.05M | -0.86% | 05/06/2024 | Get Alert |
| ADCT | ADC Therapeutics | -$0.08 | -$0.50 | -$0.97 | -94.00% | $69.80M | $15.33M | $16.79M | 9.52% | 03/13/2024 | Get Alert |
| ADCT | ADC Therapeutics | $0.13 | -$0.63 | -$0.41 | 34.92% | $76.32M | $15.99M | $14.49M | -9.36% | 11/07/2023 | Get Alert |
| ADCT | ADC Therapeutics | -$0.73 | -$0.44 | -$0.37 | 15.91% | $17.29M | $34.77M | $19.28M | -44.54% | 08/08/2023 | Get Alert |
| ADCT | ADC Therapeutics | -$0.36 | -$0.67 | -$0.53 | 20.90% | $46.50M | $20.09M | $18.99M | -5.47% | 05/09/2023 | Get Alert |
| ADCT | ADC Therapeutics | -$0.39 | -$0.29 | -$0.10 | 65.52% | $17.01M | $65.49M | $69.80M | 6.58% | 02/28/2023 | Get Alert |
| ADCT | ADC Therapeutics | -$0.59 | -$0.35 | $0.13 | 137.14% | $13.15M | $47.01M | $76.32M | 62.35% | 11/08/2022 | Get Alert |
| ADCT | ADC Therapeutics | -$0.70 | -$0.91 | -$0.73 | 19.78% | $3.76M | $20.51M | $17.29M | -15.69% | 08/09/2022 | Get Alert |
| ADCT | ADC Therapeutics | -$0.74 | -$0.70 | -$0.36 | 48.57% | $0.00 | $28.94M | $46.50M | 60.67% | 05/09/2022 | Get Alert |
| ADCT | ADC Therapeutics | -$0.82 | -$0.86 | -$0.39 | 54.65% | $0.00 | $16.46M | $17.01M | 3.34% | 03/03/2022 | Get Alert |
| ADCT | ADC Therapeutics | -$0.58 | -$0.92 | -$0.59 | 35.87% | $0.00 | $7.39M | $13.15M | 77.90% | 11/02/2021 | Get Alert |
| ADCT | ADC Therapeutics | -$0.51 | -$0.82 | -$0.70 | 14.63% | $0.00 | $2.37M | $3.76M | 58.65% | 08/03/2021 | Get Alert |
| ADCT | ADC Therapeutics | — | -$0.90 | -$0.74 | 17.78% | — | $90.00K | $0.00 | -100.00% | 05/06/2021 | Get Alert |
| ADCT | ADC Therapeutics | — | -$0.38 | -$0.82 | -115.79% | — | $860.00K | $0.00 | -100.00% | 03/18/2021 | Get Alert |
| ADCT | ADC Therapeutics | — | -$0.81 | -$0.58 | 28.40% | — | $40.00K | $0.00 | -100.00% | 11/12/2020 | Get Alert |
| ADCT | ADC Therapeutics | — | -$0.67 | -$0.51 | 23.88% | — | $290.00K | $0.00 | -100.00% | 08/18/2020 | Get Alert |
ADC Therapeutics (ADCT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-27 | $-0.25 | $-0.35 | 28.6 % |
| Q3 | 2024-11-07 | $-0.28 | $-0.39 | 28.2 % |
| Q2 | 2024-08-06 | $-0.25 | $-0.44 | 43.2 % |
| Q1 | 2024-05-06 | $-0.38 | $-0.56 | 32.1 % |
ADC Therapeutics (ADCT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-27 | $16.91M | $19.67M | -14.0 % |
| Q3 | 2024-11-07 | $18.46M | $18.46M | 0.02 % |
| Q2 | 2024-08-06 | $17.41M | $18.93M | -8.03 % |
| Q1 | 2024-05-06 | $18.05M | $18.21M | -0.86 % |
FAQ
When is ADC Therapeutics (NYSE:ADCT) reporting earnings?
ADC Therapeutics (ADCT) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on March 27, 2025 for Q4.
What were the latest earnings per share (EPS) for ADC Therapeutics (NYSE:ADCT)?
The Actual EPS was $-0.25, which beat the estimate of $-0.35.
What were ADC Therapeutics’s (NYSE:ADCT) revenues?
The Actual Revenue was $16.9M, which missed the estimate of $19.7M.
Browse earnings estimates, EPS, and revenue on all stocks.